Tamoxifen inhibits malignant peripheral nerve sheath tumor growth in an estrogen receptor-independent manner.
Neuro Oncol.
2011 Jan;13(1):28-41. doi: 10.1093/neuonc/noq146. Epub 2010 Nov 12. PubMed PMID:
21075781; PubMed Central PMCID:
PMC3018903.
ErbB membrane tyrosine kinase receptors: analyzing migration in a highly complex signaling system..
In:
Mukai H, editor.
Protein Kinase Technologies
New York: Springer; 2012. Chapter 7; p.105-131.
Genetically engineered mouse models shed new light on the pathogenesis of neurofibromatosis type I-related neoplasms of the peripheral nervous system.
Brain Res Bull.
2012 May 1;88(1):58-71. doi: 10.1016/j.brainresbull.2011.08.005. Epub 2011 Aug 10. Review. PubMed PMID:
21855613; PubMed Central PMCID:
PMC3263419.
Transgenic mice overexpressing neuregulin-1 model neurofibroma-malignant peripheral nerve sheath tumor progression and implicate specific chromosomal copy number variations in tumorigenesis.
Am J Pathol.
2013 Mar;182(3):646-67. doi: 10.1016/j.ajpath.2012.11.017. Epub 2013 Jan 13. PubMed PMID:
23321323; PubMed Central PMCID:
PMC3586689.
Malignant peripheral nerve sheath tumor invasion requires aberrantly expressed EGF receptors and is variably enhanced by multiple EGF family ligands.
J Neuropathol Exp Neurol.
2013 Mar;72(3):219-33. doi: 10.1097/NEN.0b013e3182859939. PubMed PMID:
23399900; PubMed Central PMCID:
PMC3579504.
4-Hydroxytamoxifen induces autophagic death through K-Ras degradation.
Cancer Res.
2013 Jul 15;73(14):4395-405. doi: 10.1158/0008-5472.CAN-12-3765. Epub 2013 May 30. PubMed PMID:
23722551; PubMed Central PMCID:
PMC3715566.
Neuregulin-1 overexpression and Trp53 haploinsufficiency cooperatively promote de novo malignant peripheral nerve sheath tumor pathogenesis.
Acta Neuropathol.
2014 Apr;127(4):573-91. doi: 10.1007/s00401-013-1209-3. PubMed PMID:
24232507; PubMed Central PMCID:
PMC3999224.
Improving outcomes for neurofibromatosis 1-associated brain tumors.
Expert Rev Anticancer Ther.
2015 Apr;15(4):415-23. doi: 10.1586/14737140.2015.1009043. Epub 2015 Feb 5. Review. PubMed PMID:
25652347.
Classic Ras Proteins Promote Proliferation and Survival via Distinct Phosphoproteome Alterations in Neurofibromin-Null Malignant Peripheral Nerve Sheath Tumor Cells.
J Neuropathol Exp Neurol.
2015 Jun;74(6):568-86. doi: 10.1097/NEN.0000000000000201. PubMed PMID:
25946318; PubMed Central PMCID:
PMC4433624.
Neurofibromatosis type 1-related tumours in paediatrics: an evolving treatment landscape.
Lancet Child Adolesc Health.
2020 Jul;4(7):488-490. doi: 10.1016/S2352-4642(20)30169-3. PubMed PMID:
32562630.
Temporal, spatial, and genetic constraints contribute to the patterning and penetrance of murine neurofibromatosis-1 optic glioma.
Neuro Oncol.
2021 Apr 12;23(4):625-637. doi: 10.1093/neuonc/noaa237. PubMed PMID:
33080011; PubMed Central PMCID:
PMC8041339.
R-Ras subfamily proteins elicit distinct physiologic effects and phosphoproteome alterations in neurofibromin-null MPNST cells.
Cell Commun Signal.
2021 Sep 16;19(1):95. doi: 10.1186/s12964-021-00773-4. PubMed PMID:
34530870; PubMed Central PMCID:
PMC8447793.
Children with supratentorial midline pilocytic astrocytomas exhibit multiple progressions and acquisition of neurologic deficits over time.
Neurooncol Adv.
2022 Jan-Dec;4(1):vdab187. doi: 10.1093/noajnl/vdab187. eCollection 2022 Jan-Dec. PubMed PMID:
35036914; PubMed Central PMCID:
PMC8757579.
Dose-dependent seizure control with MEK inhibitor therapy for progressive glioma in a child with neurofibromatosis type 1.
Childs Nerv Syst.
2022 Nov;38(11):2245-2249. doi: 10.1007/s00381-022-05571-y. Epub 2022 Jun 1. PubMed PMID:
35648241; PubMed Central PMCID:
PMC9617819.
Neuronal Activity in Brain Tumor Pathogenesis: Adding to the Complexities of Central Nervous System Neoplasia.
In:
Amit M, Scheff NN, editors.
Cancer Neuroscience
Cham: Springer; 2023.
Rapid symptomatic improvement in two patients with ganglioglioma after restarting BRAF inhibitor therapy.
Pediatr Blood Cancer.
2023 Jul;70(7):e30296. doi: 10.1002/pbc.30296. Epub 2023 Mar 14. PubMed PMID:
36916822; PubMed Central PMCID:
PMC10500853.
Germline BRCA2 pathogenic variants in pediatric ganglioglioma: Case report and review of the literature.
Childs Nerv Syst.
2024 May;40(5):1609-1612. doi: 10.1007/s00381-023-06267-7. Epub 2024 Jan 3. Review. PubMed PMID:
38168858.
Concurrent Collection of Fetal Murine Brain and Serum to Assess Effects of Maternal Diet on Nutrition and Neurodevelopment in Neurofibromatosis Type 1.
J Vis Exp.
2024 May 17;(207). doi: 10.3791/66226. PubMed PMID:
38829109.
Incidence and survival characteristics of pediatric ganglioglioma from 2004 to 2018, with focus on infratentorial sites.
Neurooncol Pract.
2024 Jun;11(3):328-335. doi: 10.1093/nop/npae012. eCollection 2024 Jun. PubMed PMID:
38737603; PubMed Central PMCID:
PMC11085854.
Maternal obesogenic diet operates at the tumor cell of origin to increase incidence and decrease latency of Neurofibromatosis Type 1 optic pathway glioma.
Neuro Oncol.
2024 Jul 18;. doi: 10.1093/neuonc/noae136. [Epub ahead of print] PubMed PMID:
39023130.
What would you like to do?